I am the co-founder and chief technology officer at Talus Bio. With over a decadeâs experience in analytical chemistry and computational biology, I develop technologies for quantitative proteomics. In particular, at Talus, I’m working on the challenges associated with scaling-up quantitative proteomics experiments. I am directly involved in a large variety of research projects spanning cancer drug discovery, molecular mechanisms of aging, epigenetics, and spatiotemporal proteomics. In addition to my research and leadership roles, I am an active member of several professional organizations, including the American Society for Mass Spectrometry (ASMS), the Human Proteome Organization (HUPO), and US HUPO. I am passionate about community building and mentorship, serving as an organizer for numerous workshops for proteomics, professional skills, and entrepreneurship.
When I’m not working, I enjoy bringing my son to the zoo, reading on my Kindle with a cup of coffee, and running 5ks around Seattle’s parks.
Where in the World is Lindsay?
-
Bioorganic Chemistry Gordon Research Conference
-
ð¥Chemoproteomics workshop panel moderation at ASMS
-
ð€Oral presentation at ASMS, “Integrative regulome profiling of DNA damage responses to discover DNA repair-directed therapeutics in aging”
-
ð¥Entrepreneurship workshop panel moderation at ASMS
-
ð€Sciex breakfast seminar at ASMS, “Chromatogram-based chemoproteomics with the ZenoTOF 8600 system and Skyline”
-
ð€Seminar for Stanford Proteomics Users Group (PUG)
-
ð§âð«Teaching at the “May Institute on Computation and Statistics for Mass Spectrometry and Proteomics” in Boston
-
ð€Speaking at the AI session of the Life Science Innovation NorthWest conference
-
ð¥Biotech Panel, hosted by University of Washington student organizations Project Medicine x FosterMed
-
ð€Seminar for the Bioscience Careers Seminar Series, hosted by the University of Washington PhD Ambassadors and supported by the Office of Research and Graduate Education and Life Science Washington